NEW YORK (Reuters Health) Jul 08 –
The bisphosphonate pamidronate appears to effect a radical cure in an experimental model of cutaneous leishmaniasis, researchers at the University of Illinois at Urbana-Champaign report in the July 1st issue of The Journal of Infectious Diseases.
Dr. Roberto Docampo told Reuters Health that pamidronate is known to stimulate “immune cells–gamma-delta T cells–in humans that have been shown to be important for the cure of skin diseases such as injuries and cancer.” Pamidronate has also shown in vitro action against various parasites.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!